Skip to main content
SpringerLink
Log in

In Vitro Cutaneous Disposition of a Topical Diclofenac Lotion in Human Skin: Effect of a Multi-Dose Regimen

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. This study determines comparative bioavailability of diclofenac sodium lotion compared to an aqueous solution after topical application to viable human skin in vitro. In addition, the difference between a single dose and multiple doses (8 times) was also determined.

Methods. An in vitro flow-through diffusion cell system was employed, using radiolabelled diclofenac sodium.

Results. Multiple doses of lotion (2 μl/cm2 and 5 μl/cm2) delivered a total of 40.1 ± 17.6 μg and 85.6 ± 41.4 μg diclofenac, respectively, at 48 h, compared to only 9.4 ± 2.9 μg and 35.7 ± 19.0 μg absorbed after topical application of diclofenac as an aqueous solution (P < 0.05). A single dose study showed no statistical difference between diclofenac delivered in lotion or an aqueous solution. Over 48 h the total absorption from lotion was 10.2 ± 6.7 μg and 26.2 ± 17.6 μg (2 μl/cm2 and 5 μl/cm2, respectively), compared to 8.3 ± 1.5 μg and 12.5 ± 5.7 μg from an aqueous solution. Both single doses of lotion and aqueous diclofenac showed decreased diclofenac absorption into the receptor fluid between 12 and 24 h. However, when applied multiple times, absorption from lotion was continually increasing up to 48 h. The total dose accountability ranged from 76.8 ± 8.2% to 110.6 ± 15.1% of the applied dose.

Conclusions. Diclofenac lotion exhibited enhanced diclofenac percutaneous absorption rate through human skin (mass, flux and partition coefficient) when applied a multiple number of times and this enhanced absorption was maintained over 48 h. This suggests that a constituent of the lotion (DMSO) will enhance human skin absorption of diclofenac when used in a multi-dose regimen, but not after a single dose.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. B. L. Seth. Comparative pharmacokinetics and bioavailability study of percutaneous absorption of diclofenac from two topical formulations containing drug as a solution gel and as an emulsion gel. Arzneim-Forsch. 42:120–122 (1992).

    Google Scholar 

  2. H.-O. Ho, F.-C. Huang, T. D. Sokoloski, and M.-T. Shue. The influence of cosolvents on the in vitro percutaneous penetration of diclofenac sodium from a gel system. J. Pharm. Pharmacol. 46:636–642 (1994).

    Google Scholar 

  3. A. Sioufi, F. Pommier, F. Boschet, J. Godbillion, D. Lauoignat, and D. Salliere. Percutaneous absorption of diclofenac in healthy volunteers after single and repeated topical application of diclofenac emulgel. Biopharmaceut. Drug Disp. 15:441–449 (1992).

    Google Scholar 

  4. S. P. Vyas, R. Singh, and R. K. Asati. Liposomally encapsulated diclofenac for sonophoresis induced systemic delivery. J. Microencapsulation. 12:149–154 (1995).

    Google Scholar 

  5. T. Nishihata, K. Kotera, Y. Nakano, and M. Yamamazaki. Rat percutaneous transport of diclofenac and influence of hydrogenated soya lecitin. Chem. Pharm. Bull. 35:3807–3812 (1987).

    Google Scholar 

  6. Y. Obata, K. Takayama, H. Okabe, and T. Nagai. Effect of cyclic monoterpenes on percutaneous absorption in the case of a water-soluble drug (diclofenac sodium). Drug Des. Del. 6:319–328 (1991).

    Google Scholar 

  7. T. Nishihata, A. Kamada, K. Takahashi, K. Matsumoto, K. Shinozaki, Y. Tabata, M. Keigami, T. Miyagi, and N. Tastumi. Percutaneous absorption of diclofenac in rats and humans: Aqueous gel formulation. Int. J. Pharm. 46:1–7 (1988).

    Google Scholar 

  8. L. N. Hurst, D. H. Brown, and K. A. Murray. Prolonged life and improved quality for stored skin grafts. Plas. Reconstr. Surg. 73:105–109 (1984).

    Google Scholar 

  9. R. L. Bronaugh, R. F. Stewart, and J. E. Storm. Extent of cutaneous matabolism during percutaneous absorption of xenobiotics. Toxicol. Appl. Pharmacol. 99:534–543 (1989).

    Google Scholar 

  10. R. C. Wester, J. Christoffel, T. Hartway, N. Poblete, and H. I. Maibach. Cadaver human skin viability for in vitro percutaneous absorption: Storage and detrimental effects of heat-separation and freezing. Pharm. Res. 15:82–84 (1998).

    Google Scholar 

  11. R. C. Wester, P. K. Noonan, and H. I. Maibach. Variations in percutaneous absorption of testosterone in the rhesus monkey due to anatomic site of application and frequency of appliation. Arch. Dermatol. Res. 116:186–188 (1980).

    Google Scholar 

  12. R. C. Wester and H. I. Maibach. Cutaneous pharmacokinetics: 10 steps to percutaneous absorption. Drug Met. Rev. 14:169–205 (1983).

    Google Scholar 

  13. R. C. Wester, J. Melendres, L. Sedik, and H. I. Maibach. Percutaneous absorption of azone following single and multiple doses to human volunteers. J. Pharm. Sci. 83:124–125 (1994).

    Google Scholar 

  14. J. Radermacher, D. Jentsch, M. A. Scholl, T. Lustinetz, and J. C. Frolich. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br. J. Clin. Pharmacol. 31:537–541 (1991).

    Google Scholar 

  15. D. A. W. Bucks, H. I. Maibach, and R. H. Guy. Percutaneous absorption of steroids: Effect of repeated application. J. Pharm. Sci. 74:1337–1339 (1985).

    Google Scholar 

  16. R. C. Wester, P. K. Noonan, and H. I. Maibach. Percutaneous absorption of hydrocortisone increases with long-term administration: In vivo studies in the rhesus monkey. Arch. Dermatol. 116:186–188 (1980).

    Google Scholar 

  17. M. Muller, H. Mascher, C. Kikuta, S. Schafer, M. Brunner, G. Domer, and H. G. Eichler. Diclofenac concentrations in defined tissue layers after topical administration. Clin. Pharmacol. Ther. 62:293–299 (1997).

    Google Scholar 

  18. R. B. Stoughton. Dimethylsulfoxide induction of a steroid reservoir in human skin. Arch. Dermatol. 91: 657–660 (1965).

    Google Scholar 

  19. W. W. Shen, A. G. Danti, and F. N. Bruscato. Effect of nonionic surfactants on percutaneous absorption of salicylic acid and sodium salicylate in the presence of dimethylsulfoxide. J. Pharm. Sci. 65: 1780–1783 (1976).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University of California, San Francisco, Surge Laboratory, Box 0989, San Francisco, California, 94143

    Philip G. Hewitt, Nicholas Poblete, Ronald C. Wester & Howard I. Maibach

  2. Department of Toxicology, E. Merck, Frankfurter Strasse 250, 64293, Darmstadt, pGermany

    Philip G. Hewitt

  3. Dimethaid Research Inc., 144 Steelcase Road West, Markham, Ontario, Canada

    J. Zev Shainhouse

Authors
  1. Philip G. Hewitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicholas Poblete
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ronald C. Wester
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Howard I. Maibach
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Zev Shainhouse
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hewitt, P.G., Poblete, N., Wester, R.C. et al. In Vitro Cutaneous Disposition of a Topical Diclofenac Lotion in Human Skin: Effect of a Multi-Dose Regimen. Pharm Res 15, 988–992 (1998). https://doi.org/10.1023/A:1011961607089

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011961607089

Search

Navigation